In CML patients Pim-1 is essential for BCR-ABL mediated in vivo transformation and leukemogenesis [138]; and simultaneous knockdown of Pim-1 and Pim-2 in cells transformed by BCR-ABL eliminated growth factor dependent growth [139]. Here, PIM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.